Tetanus-diphtheria vaccination in adults: the long-term persistence of antibodies is not dependent on polyclonal B-cell activation and the defective response to diphtheria toxoid re-vaccination is associated to HLADRB1∗01.

[1]  T. Schwarz,et al.  Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older , 2017, The Journal of infectious diseases.

[2]  J. Sidney,et al.  Lack of evidence for post-vaccine onset of autoimmune/lymphoproliferative disorders, during a nine-month follow-up in multiply vaccinated Italian military personnel. , 2017, Clinical immunology.

[3]  R. Booy,et al.  Tetanus–diphtheria–pertussis vaccine may suppress the immune response to subsequent immunization with pneumococcal CRM197-conjugate vaccine (coadministered with quadrivalent meningococcal TT-conjugate vaccine): a randomized, controlled trial⋆ , 2017, Journal of travel medicine.

[4]  S. Romero-Steiner,et al.  Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone , 2016, Clinical and Vaccine Immunology.

[5]  M. Mori,et al.  Durability of Vaccine-Induced Immunity Against Tetanus and Diphtheria Toxins: A Cross-sectional Analysis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  K. Edwards.  Maternal antibodies and infant immune responses to vaccines. , 2015, Vaccine.

[7]  B. Plikaytis,et al.  The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines. , 2014, Vaccine.

[8]  V. Pankratz,et al.  HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication study , 2014, Human Genetics.

[9]  D. Fuchs,et al.  Recall Responses to Tetanus and Diphtheria Vaccination Are Frequently Insufficient in Elderly Persons , 2013, PloS one.

[10]  Silvia Guzmán-Beltrán,et al.  Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees , 2013, BMC Infectious Diseases.

[11]  F. Sallusto,et al.  The who's who of T‐cell differentiation: Human memory T‐cell subsets , 2013, European journal of immunology.

[12]  F. Lozupone,et al.  Dormant Mycobacterium tuberculosis Fails To Block Phagosome Maturation and Shows Unexpected Capacity To Stimulate Specific Human T Lymphocytes , 2013, The Journal of Immunology.

[13]  T. Vesikari,et al.  Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials , 2013, The Lancet.

[14]  B. Gärtner,et al.  CD4+ T‐cell immunity after pandemic influenza vaccination cross‐reacts with seasonal antigens and functionally differs from active influenza infection , 2012, European journal of immunology.

[15]  M. Slifka,et al.  Contributions of humoral and cellular immunity to vaccine-induced protection in humans. , 2011, Virology.

[16]  N. Andrews,et al.  Safety and Immunogenicity of Coadministering a Combined Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine with 7-Valent Pneumococcal Conjugate Vaccine and Measles, Mumps, and Rubella Vaccine at 12 Months of Age , 2010, Clinical and Vaccine Immunology.

[17]  Y. Juhn,et al.  Assessment of humoral and cell-mediated immune response to measles-mumps-rubella vaccine viruses among patients with asthma. , 2010, Allergy and asthma proceedings.

[18]  R. Ahmed,et al.  From vaccines to memory and back. , 2010, Immunity.

[19]  M. Slifka,et al.  Mechanisms that determine plasma cell lifespan and the duration of humoral immunity , 2010, Immunological reviews.

[20]  I. Donatelli,et al.  Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity. , 2010, Clinical immunology.

[21]  R. Vierkant,et al.  HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine. , 2009, Vaccine.

[22]  L. Picker,et al.  Effector-memory T cell responses are associated with protection of rhesus monkeys from mucosal SIV challenge , 2009, Nature Medicine.

[23]  S. Esposito,et al.  Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine. , 2009, Vaccine.

[24]  R. Jacobson,et al.  Personalized vaccines: the emerging field of vaccinomics , 2008, Expert opinion on biological therapy.

[25]  R. Vierkant,et al.  Human Leukocyte Antigen and Cytokine Receptor Gene Polymorphisms Associated With Heterogeneous Immune Responses to Mumps Viral Vaccine , 2008, Pediatrics.

[26]  Maria Augusta Santos,et al.  Levels of diphtheria and tetanus specific IgG of Portuguese adult women, before and after vaccination with adult type Td. Duration of immunity following vaccination , 2007, BMC public health.

[27]  Kenneth G. C. Smith,et al.  Competence and competition: the challenge of becoming a long-lived plasma cell , 2006, Nature Reviews Immunology.

[28]  F. Stevenson,et al.  Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific. , 2006, Blood.

[29]  G. Carcelain,et al.  Distinct Time Effects of Vaccination on Long-Term Proliferative and IFN-γ–producing T Cell Memory to Smallpox in Humans , 2004, The Journal of experimental medicine.

[30]  R. Kaslow,et al.  HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination , 2004, Hepatology.

[31]  M. Newport,et al.  Genetic regulation of immune responses to vaccines in early life , 2004, Genes and Immunity.

[32]  Antonio Lanzavecchia,et al.  Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells , 2002, Science.

[33]  M. Wharton,et al.  Serologic Immunity to Diphtheria and Tetanus in the United States , 2002, Annals of Internal Medicine.

[34]  R. Vierkant,et al.  Identification of an association between HLA class II alleles and low antibody levels after measles immunization. , 2001, Vaccine.

[35]  M. Roelants,et al.  The effect of reconstitution of an Haemophilus influenzae type b-tentanus toxoid conjugate (PRP-T) vaccine on the immune responses to a diphtheria-tetanus-whole cell pertussis (DTwP) vaccine: a five-year follow-up. , 1999, Vaccine.

[36]  C. Leclerc,et al.  Reduced Response to Multiple Vaccines Sharing Common Protein Epitopes That Are Administered Simultaneously to Infants , 1998, Infection and Immunity.

[37]  F. Laforce,et al.  Protection against tetanus. , 1995, The New England journal of medicine.

[38]  R. Van Ree,et al.  IgE antibodies to tetanus toxoid in relation to atopy. , 1995, International archives of allergy and immunology.

[39]  P. Matricardi,et al.  Prevalence of hyperimmunization against tetanus in Italians born after the introduction of mandatory vaccination of children with tetanus toxoid in 1968 , 1993, Infection.

[40]  R. Rappuoli,et al.  Absence of protective immunity against diphtheria in a large proportion of young adults. , 1993, Vaccine.

[41]  Schröder Jp,et al.  Tetanus immunity in men and women in the Federal Republic of Germany , 1991 .

[42]  N. Masurel,et al.  HL‐A Linked Genetic Control of Immune Response in Man , 1975, Transplantation reviews.

[43]  J. A. Mccomb.  THE PROPHYLACTIC DOSE OF HOMOLOGOUS TETANUS ANTITOXIN. , 1964, The New England journal of medicine.

[44]  J. Ipsen,et al.  Circulating antitoxin at the onset of diphtheria in 425 patients. , 1946, Journal of immunology.

[45]  Brian J. Smith,et al.  Antibody response to pneumococcal vaccination as a function of preimmunization titer. , 2009, The Journal of allergy and clinical immunology.

[46]  B. Heyman,et al.  Regulation of antibody responses via antibodies, complement, and Fc receptors. , 2000, Annual review of immunology.

[47]  P. Matricardi,et al.  Tetanus immunity among Italians born after the introduction of mandatory vaccination of children. , 1993, Vaccine.

[48]  J. P. Schröder,et al.  [Tetanus immunity in men and women in the Federal Republic of Germany]. , 1991, Immunitat und Infektion.

[49]  P. Terasaki,et al.  HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. , 1976, The New England journal of medicine.

[50]  J. Uhr,et al.  Regulatory effect of antibody on the immune response. , 1968, Advances in immunology.

[51]  I. Scheibel.  The uses and results of active tetanus immunization. , 1955, Bulletin of the World Health Organization.